CoChat

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

Open access
Donati, Benedetta, Pietrelli, Alessandro, Pingitore, Piero, Dongiovanni, Paola, Caddeo, Andrea, Walker, Lucy, Baselli, Guido, Pelusi, Serena, Rosso, Chiara, Vanni, Ester, Daly, Ann, Mancina, Rosellina Margherita, Grieco, Antonio, Miele, Luca, Grimaudo, Stefania, Craxi, Antonio, Petta, Salvatore, De Luca, Laura, Maier, Silvia, Soardo, Giorgio, Bugianesi, Elisabetta, Colli, Fabio, Romagnoli, Renato, Anstee, Quentin M., Reeves, Helen L., Fracanzani, Anna Ludovica, Fargion, Silvia, Romeo, Stefano, Valenti, Luca · 2017 · Cancer Medicine
Cited by 52

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

In an increasing proportion of cases, hepatocellular carcinoma (HCC) develops in patients with nonalcoholic fatty liver disease (NAFLD). Mutations in telomerase reverse transcriptase (hTERT) are associated with familial liver diseases. The aim of this study was to examine telomere length and germline hTERT mutations as associated with NAFLD‐HCC. In 40 patients with NAFLD‐HCC, 45 with NAFLD‐cirrhosis and 64 healthy controls, peripheral blood telomere length was evaluated by qRT‐PCR and hTERT coding regions and intron–exon boundaries sequenced. We further analyzed 78 patients affected by primary liver cancer (NAFLD‐PLC, 76 with HCC). Enrichment of rare coding mutations (allelic frequency <0.001) was evaluated by Burden test. Functional consequences were estimated in silico and by over‐expressing protein variants in HEK‐293 cells. We found that telomere length was reduced in individuals with NAFLD‐HCC versus those with cirrhosis (P = 0.048) and healthy controls (P = 0.0006), independently of age and sex. We detected an enrichment of hTERT mutations in NAFLD‐HCC, that was confirmed when we further considered a larger cohort of NAFLD‐PLC, and was more marked in female patients (P = 0.03). No mutations were found in cirrhosis and local controls, and only one in 503 healthy Europeans from the 1000 Genomes Project (allelic frequency = 0.025 vs. <0.001; P = 0.0005). Mutations with predicted functional impact, including the frameshift Glu113Argfs*79 and missense Glu668Asp, cosegregated with liver disease in two families. Three patients carried missense mutations (Ala67Val in homozygosity, Pro193Leu and His296Pro in heterozygosity) in the N‐terminal template‐binding domain (P = 0.037 for specific enrichment). Besides Glu668Asp, the Ala67Val variant resulted in reduced intracellular protein levels. In conclusion, we detected an association between shorter telomeres in peripheral blood and rare germline hTERT mutations and NAFLD‐HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cam4.1078

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 52

Metadata

Authors
Donati, B., Pietrelli, A., Pingitore, P., Dongiovanni, P., Caddeo, A., Walker, L., Baselli, G., Pelusi, S., Rosso, C., Vanni, E., Daly, A., Mancina, R. M., Grieco, A., Miele, L., Grimaudo, S., Craxi, A., Petta, S., De Luca, L., Maier, S., Soardo, G., Bugianesi, E., Colli, F., Romagnoli, R., Anstee, Q. M., Reeves, H. L., Fracanzani, A. L., Fargion, S., Romeo, S., & Valenti, L.
Venue
Cancer Medicine
Publisher
Wiley
Published
2017-07-04
Volume
6
Issue
8
Pages
1930-1940
ISSN
2045-7634 (ISSN-L)
OpenAlex
W2726866747
Cited by
52
References
15
FWCI
3.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. https://app.cochat.ai/papers/10.1002/cam4.1078
The paper
Donati, B., Pietrelli, A., Pingitore, P., Dongiovanni, P., Caddeo, A., Walker, L., Baselli, G., Pelusi, S., Rosso, C., Vanni, E., Daly, A., Mancina, R. M., Grieco, A., Miele, L., Grimaudo, S., Craxi, A., Petta, S., De Luca, L., Maier, S., . . . Valenti, L. (2017). Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. Cancer Medicine. https://doi.org/10.1002/cam4.1078

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.